Literature DB >> 16904902

The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation.

Janine A Overcash1, Jason Beckstead, Linda Moody, Martine Extermann, Sara Cobb.   

Abstract

UNLABELLED: The abbreviated CGA (aCGA) can be used as a prescreening assessment to identify patients who would most benefit from the complete CGA.
OBJECTIVE: To develop cutpoints for scoring the aCGA that are consistent with existing limitations as revealed by the full CGA. DESIGN/
SETTING: A retrospective chart review of patients at the H. Lee Moffitt Cancer Center. PARTICIPANTS: Over 500 charts between 1995 and 2001 were reviewed on cancer patients 70 and over. MEASUREMENTS: Each of the four domains: functional status (activities of daily living (ADL), instrumental activities of daily living (IADL), depression, using the geriatric depression scale (GDS), and cognition using the mini-mental state examination (MMSE)) are scored separately.
RESULTS: For the depression domain, a score of 2 or more toward depression indicates that the entire GDS be administered. For the MMSE, a score of 6 or lower indicates necessity of the entire MMSE. For the ADL/IADL, any deficit on either scale (needs assistance or complete assistance) requires further clinical evaluation using the entire instruments.
CONCLUSIONS: These guidelines provide the clinician with parameters to target patients most likely to benefit from more intensive geriatric evaluation.

Entities:  

Mesh:

Year:  2006        PMID: 16904902     DOI: 10.1016/j.critrevonc.2006.04.003

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  36 in total

1.  Senior adult oncology.

Authors:  Arti Hurria; Ilene S Browner; Harvey Jay Cohen; Crystal S Denlinger; Mollie deShazo; Martine Extermann; Apar Kishor P Ganti; Jimmie C Holland; Holly M Holmes; Mohana B Karlekar; Nancy L Keating; June McKoy; Bruno C Medeiros; Ewa Mrozek; Tracey O'Connor; Stephen H Petersdorf; Hope S Rugo; Rebecca A Silliman; William P Tew; Louise C Walter; Alva B Weir; Tanya Wildes
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

2.  The importance of negative predictive value (NPV) of vulnerable elderly survey (VES 13) as a pre-screening test in older patients with cancer.

Authors:  B Castagneto; C Di Pietrantonj; I Stevani; A Anfossi; M Arzese; L Giorcelli; L Giaretto
Journal:  Med Oncol       Date:  2013-08-31       Impact factor: 3.064

3.  Geriatric oncology: an overview of progresses and challenges.

Authors:  Martine Extermann
Journal:  Cancer Res Treat       Date:  2010-06-30       Impact factor: 4.679

Review 4.  The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer.

Authors:  Marije E Hamaker; Alinda G Vos; Carolien H Smorenburg; Sophia E de Rooij; Barbara C van Munster
Journal:  Oncologist       Date:  2012-08-31

Review 5.  Determining chemotherapy tolerance in older patients with cancer.

Authors:  Jerome Kim; Arti Hurria
Journal:  J Natl Compr Canc Netw       Date:  2013-12-01       Impact factor: 11.908

6.  Examining five- and ten-year survival in older women with breast cancer using cancer-specific geriatric assessment.

Authors:  Kerri M Clough-Gorr; Soe Soe Thwin; Andreas E Stuck; Rebecca A Silliman
Journal:  Eur J Cancer       Date:  2011-07-07       Impact factor: 9.162

Review 7.  How to implement a geriatric assessment in your clinical practice.

Authors:  Schroder Sattar; Shabbir M H Alibhai; Hans Wildiers; Martine T E Puts
Journal:  Oncologist       Date:  2014-09-03

8.  Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up.

Authors:  Kerri M Clough-Gorr; Andreas E Stuck; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

9.  Utility of a chemotherapy toxicity prediction tool for older patients in a community setting.

Authors:  C Mariano; R Jamal; P Bains; S Hejazi; L Chao; J Wan; J Ho
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

10.  Toxicity of initial chemotherapy in older patients with lung cancers.

Authors:  Marjorie G Zauderer; Camelia S Sima; Beatriz Korc-Grodzicki; Mark G Kris; Lee M Krug
Journal:  J Geriatr Oncol       Date:  2013-01       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.